Colonial River Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Colonial River Investments's BMY Position: Q1 2025 in Review
Colonial River Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 4,441 shares — an estimated $251K sold.
Colonial River Investments first reported a position in BMY in Q4 2020 and held it in 16 quarters. The position peaked at $600K in Q2 2021. 2,486 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Colonial River Investments reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Colonial River Investments sold 4,441 Bristol-Myers Squibb shares in Q1 2025, an estimated $251K.
- Colonial River Investments first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 16 quarters.
- Colonial River Investments's Bristol-Myers Squibb position peaked at $600K in Q2 2021.
- 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Colonial River Investments's 13F filing for Q1 2025, filed 25 Apr 2025.